4 Scary Stock Tops To Avoid

Company: Regeneron Pharmaceuticals

Sector: Health Care

Sub-Industry: Biotechnology

Key Valuation Metrics:

  • Price to Cash Flow (P/CF): 30.2x
  • Price to Earnings (P/E): 63.2x
  • Price to Book Value (P/BV): 11x
  • Normalized P/CF (5-year trailing): 78.2x
  • Normalized P/E: 98.5x
  • Normalized P/B: 19.3x

1 - Copy - Copy (2)

Company: McKesson Corp

Sector: Health Care

Sub-Industry: Health Care Distributors

Key Valuation Metrics:

  • Price to Cash Flow (P/CF): 11.6x
  • Price to Earnings (P/E): 20.3x
  • Price to Book Value (P/BV): 3.8x
  • Normalized P/CF: 13.1x
  • Normalized P/E: 26.1x
  • Normalized P/B: 4.5x

1 - Copy - Copy

Company: WABCO

Sector: Industrials

Sub-Industry: Construction Machinery & Heavy Trucks

Key Valuation Metrics:

  • Price to Cash Flow (P/CF): 13.5x
  • Price to Earnings (P/E): 19.4x
  • Price to Book Value (P/BV): 6.4x
  • Normalized P/CF: 20.4x
  • Normalized P/E: 23x
  • Normalized P/B: 4.5x

1 - Copy (2)

Company: Middleby Corp

Sector: Industrials

Sub-Industry: Industrial Machinery

Key Valuation Metrics:

  • Price to Cash Flow (P/CF): 22.7x
  • Price to Earnings (P/E): 27.4x
  • Price to Book Value (P/BV): 5.3x
  • Normalized P/CF: 35.3x
  • Normalized P/E: 40.9x
  • Normalized P/B: 7.6x

1 - Copy

Read more commentaries by GaveKal Capital